Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago.
Wayne K. Goodman, MD, Professor and Chair of the Department of Psychiatry at Mount Sinai School of Medicine, has been chosen to receive the 2012 Outstanding Career Achievement Award from the International OCD (Obsessive Compulsive Disorder) Foundation. The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago, during the keynote address on July 28.
"Throughout my career, I have investigated the phenomenology, neurobiology, and treatment of OCD," said Dr. Goodman. "In recent years, I have focused on developing approaches to treatment-resistant OCD, including the study of Deep Brain Stimulation. To be recognized by the OCD Foundation with this award is a tremendous honor and I share it with my exceptional team at Mount Sinai, and all of those I have worked with over the last 25 years."
In the course of his research, Dr. Goodman was one of the first investigators to test and establish the efficacy of Selective Serotonin Reuptake Inhibitors (SSRIs) in OCD, and he developed the use of adjunctive antipsychotic medications in SSRI-resistant OCD.
As an expert in the development and application of deep brain stimulation for treatment-resistant OCD, Dr. Goodman works closely in the operating room with neurosurgeons to test the emotional and behavioral effects of the device when the patient is awake. After surgery, he monitors the patient and calibrates the device as needed. In deep brain stimulation, an implanted device delivers direct electrical stimulation to the brain.
In 1986, Dr. Goodman co-founded the nonprofit International OCD Foundation—the primary patient advocacy organization for OCD and related disorders. For ten years, Dr. Goodman served as the first Chair of the International OCD Foundation's Scientific Advisory Board.
In addition to his pioneering work in OCD, Dr. Goodman is an expert psycho-pharmacologist who previously served as Chair of the Food and Drug Administration's Psychopharmacologic Drug Advisory Committee. He works closely with Mount Sinai's Friedman Brain Institute to conduct research on neuropsychiatric disorders such as mood depression, autism, schizophrenia, Alzheimer's disease, and bipolar disorder.
Dr. Goodman has published more than 250 articles and serves on the editorial board of several major medical journals.
Prior to joining Mount Sinai, Dr. Goodman served as Director of the Division of Adult Translational Research and Treatment Development at the National Institutes of Mental Health (NIMH) in Bethesda, Maryland. Before the NIMH, Dr. Goodman served as Chair of the Department of Psychiatry at the University of Florida College of Medicine for nine years. Dr. Goodman was an undergraduate at Columbia University, received his medical degree from Boston University School of Medicine, and completed his residency and fellowship in psychiatry at Yale University, where he remained a faculty member until 1993.
About the Mount Sinai OCD Treatment Center
At the Mount Sinai OCD Treatment Center, Dr. Goodman leads a team of multidisciplinary clinicians who use evidence-based science to treat Tic, OCD, and related disorders across the lifespan. The Division of Tics, Obsessive-compulsive, and Related Disorders (DTOR) specialize in treating patients of all ages who suffer from these conditions. A range of different treatment modalities is available, including Cognitive Behavioral Therapy and medications. Investigational medication trials and DBS are available for treatment-resistant cases.
Patients have access to expert consultations, comprehensive evaluations, and ongoing treatment programs. Ultimately, the goal of the DTOR is to discover the causes of Tic, Obsessive-compulsive and Related Disorders, so that new and better treatments can be developed.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.